Dental Patient-Reported Outcomes Update 2021

Hua, Fang

doi:10.1016/j.jebdp.2021.101663

Cited by 5 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Aesthetics and patient satisfaction are considered key elements that must be evaluated for all treatments [ 33 , 34 ]. In this study, there were no differences in the formation of soft tissue (papilla) of the tooth-implant space, implant SR, clinical peri-implant parameters, prosthetic complications, or patient satisfaction, except for aesthetics, comfort, and self-esteem, between the TG (2.9 mm) and the CG (3.3 mm) at 12 months.…”

Section: Discussionmentioning

confidence: 99%

“…The success of implant treatment is determined by the SR and the peri-implant soft tissues, which must be congruent with the gingiva of the adjacent teeth [ 32 ]. In addition, the patient-reported outcome measures (PROMs) [ 33 ] with the aesthetic and functional results [ 34 ] are important and contribute to outcomes being considered successful [ 32 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical analysis of the tooth-implant papilla for two narrow-diameter titanium-zirconium implants in the anterior area: prospective controlled clinical study

Herrera-Pérez,

García-De-La-Fuente,

Andia-Larrea

et al. 2024

BMC Oral Health

View full text Add to dashboard Cite

Background Rehabilitation of the anterior area when the mesio-distal space is reduced is a challenge for the clinician, due to the patient’s anatomical limitations and aesthetic requirements. Narrow Diameter Implants (NDI) are an option of treatment when the standard diameter implant is not possible, but the evidence is scarce. This prospective clinical study aims to analyze the formation of the tooth-implant papilla between the implant and the adjacent natural tooth in the maxillary lateral incisors and mandibular incisors. Methods A total of 40 patients treated with NDI, of titanium-zirconium (Ti-Zr) alloy i.e., 2.9 mm Test Group (TG) and 3.3 mm Control Group (CG), were included. The mesiodistal distance between the adjacent natural teeth was used for implant selection, maintaining 1.5 mm between the fixation and the adjacent tooth. Clinical assessment was performed by a clinical examiner at 6 and 12 months after the final prosthesis. The primary variable was the Jemt Papillary Index. Also, implant survival rate (SR), complications, Implant Stability Quotient (ISQ), and patient-reported outcomes measures (PROMs) such as aesthetics, chewing, phonation, comfort, and self-esteem were analyzed. Results A significant amount of papilla filling was observed concerning the baseline, with a trend towards more formation of the papilla in the TG, with a JPI score of 3. No significant differences were observed between the two groups regarding implant SR, clinical parameters, and complications. In terms of PROMs, a higher satisfaction in the TG was observed, with significant intergroup differences for aesthetics, comfort, self-esteem, and primary stability ISQ (TG: 59.05 (SD: 5.4) vs. CG: 51.55 (SD: 5.7)). Conclusions The 2.9 mm diameter Ti-Zr implants achieved a formation of papilla similar to 3.3 mm implants in the anterior region at 12 months of follow-up after the final prosthetic restoration. The use of Ti-Zr implants with a diameter of 2.9 mm to rehabilitate single teeth in areas of the anterior region, where the mesiodistal distance is limited, showed favorable clinical results and a high degree of satisfaction during 1 year of observation similar to 3.3 mm dental implants. Trial registration This study was retrospectively registered in ClinicalTrials.gov with the number NCT05642520, dated 18/11/2022.

show abstract

Section: Discussionmentioning

confidence: 99%